Stratec SE

Report azionario XTRA:SBS

Capitalizzazione di mercato: €207.1m

Stratec Crescita futura

Criteri Future verificati 4/6

Stratec prevede che gli utili e i ricavi cresceranno rispettivamente di 36.6% e 7.2% all'anno. Si prevede che l'EPS crescerà di 38.8% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 8.6% in 3 anni.

Informazioni chiave

36.6%

Tasso di crescita degli utili

38.75%

Tasso di crescita dell'EPS

Medical Equipment crescita degli utili13.5%
Tasso di crescita dei ricavi7.2%
Rendimento futuro del capitale proprio8.61%
Copertura analitica

Good

Ultimo aggiornamento12 May 2026

Aggiornamenti recenti sulla crescita futura

Articolo di analisi Nov 11

Stratec SE (ETR:SBS) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Stratec SE ( ETR:SBS ) shareholders are probably feeling a little disappointed, since its shares fell 5.2% to €21.75 in...

Recent updates

Aggiornamento della narrazione May 08

SBS: Lower Growth Assumptions Will Still Allow Future Upside Potential

The analyst fair value estimate for Stratec has been revised from about €26.00 to about €20.00, as analysts trim price targets and factor in lower revenue growth assumptions, softer profit margin expectations, and a higher implied future P/E, in line with recent target cuts from major banks. Analyst Commentary Recent Street research reflects a more cautious stance on Stratec, with price targets revised lower and expectations reset around revenue growth and profitability.
Aggiornamento della narrazione Apr 21

SBS: Rebased Fair Value And 2025 Margin Guidance Will Define Upside Potential

The analyst price target for Stratec has been cut from about €44.96 to €34.00, as analysts factor in updated fair value, discount rate, growth, margin, and P/E assumptions following recent target revisions from major banks. Analyst Commentary Recent research suggests that while headline price targets for Stratec have come down, some bullish analysts still see potential upside at current levels.
Aggiornamento della narrazione Apr 06

SBS: Future Upside Will Rely On Reset Margins And Higher P/E

Narrative Update on Stratec The updated analyst price target for Stratec is €28.46, reflecting recent target cuts of up to €12 from prior Street research as analysts factor in a slightly higher discount rate, modestly adjusted profit margin assumptions, and a higher future P/E multiple. Analyst Commentary Recent research commentary on Stratec has focused on recalibrating price targets while keeping an eye on execution risk and the valuation investors are being asked to pay.
Aggiornamento della narrazione Mar 23

SBS: Future Upside Will Depend On Repriced Earnings Power And Margins

Analysts have trimmed their average price target for Stratec by around €2.40, with recent cuts to €34 helping to explain a slightly lower fair value estimate and modestly softer assumptions for growth, margins and future P/E. Analyst Commentary Recent research revisions on Stratec point to a reset in expectations, with lower price targets feeding into updated views on valuation, execution risk and growth assumptions.
Aggiornamento della narrazione Mar 09

SBS: Higher Discount Rate And Index Removal Will Still Allow Future Upside

Narrative Update on Stratec The analyst price target for Stratec has been reduced by €1, as analysts reflect slightly adjusted assumptions around discount rates, revenue growth and profit margins in their updated models. Analyst Commentary Bearish analysts trimming their price targets, including the recent €1 reduction, are signaling a more cautious stance on Stratec.
Aggiornamento della narrazione Feb 22

SBS: Higher Discount Rate Will Still Allow Future Upside Potential

Analysts have reduced their price target on Stratec by €1 to €26, reflecting updated assumptions regarding the company’s discount rate, revenue growth, profit margin and future P/E profile. Analyst Commentary Bearish analysts cutting the price target to €26 are signaling a more cautious stance on Stratec’s risk and reward trade off at current levels.
Aggiornamento della narrazione Feb 08

SBS: Future Upside Will Rely On Earnings Power And Cost Controls

Narrative update on Stratec Analysts have trimmed their 12 month price target on Stratec by about €1, reflecting updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent research updates on Stratec point to a small pullback in published price targets, with a reduction of about €1 in the latest move and a prior cut from €30 to €27.
Aggiornamento della narrazione Jan 23

SBS: Future Margin Recovery Will Rely On Efficiency Gains And Cost Controls

Analysts have trimmed their price target on Stratec, with the average moving slightly lower in line with a recent cut from €30 to €27, citing updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent research points to a more cautious stance on Stratec, with the reduced €27 price target reflecting updated views on what analysts see as fair value, the applied discount rate, revenue growth assumptions, margin profile and future P/E expectations.
Articolo di analisi Jan 10

Returns On Capital Signal Tricky Times Ahead For Stratec (ETR:SBS)

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...
Aggiornamento della narrazione Jan 08

SBS: Index Exit And 2025 Margin Guidance Will Define Upside Potential

Analysts have trimmed their fair value estimate for Stratec from about €51.00 to roughly €44.96. This aligns with a recent reduction in the Street price target to €27 from €30 as they factor in updated assumptions on discount rates, revenue growth, profit margins, and future P/E multiples.
Aggiornamento della narrazione Dec 18

SBS: Margin Recovery Outlook Will Support Upside Despite Reduced Price Objective

Analysts have trimmed their price target on Stratec to EUR 27.00 from EUR 30.00, reflecting slightly more cautious assumptions on long term growth, a higher discount rate, and a modestly lower future P E multiple, despite marginally improved margin expectations. Analyst Commentary Bearish analysts have highlighted that the reduction in the price target to EUR 27.00 signals a more guarded stance on Stratec's medium to long term prospects, even as the rating on the shares remains unchanged at Hold.
Aggiornamento della narrazione Dec 04

SBS: Future Margin Gains Will Emerge As Cost Controls Take Hold

Analysts have modestly reduced their price target on Stratec, trimming it by EUR 3 to EUR 27. This reflects slightly lower long term return expectations while maintaining a cautious stance on the shares.
Articolo di analisi Nov 29

Stratec (ETR:SBS) Takes On Some Risk With Its Use Of Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Aggiornamento della narrazione Nov 20

SBS: Margins Will Improve With Cost Management And Leadership Changes

The analyst price target for Stratec has been revised downward from €30 to €27. Analysts cited a slightly higher discount rate and modest changes in growth and profitability expectations as key drivers behind the adjustment.
Articolo di analisi Nov 11

Stratec SE (ETR:SBS) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Stratec SE ( ETR:SBS ) shareholders are probably feeling a little disappointed, since its shares fell 5.2% to €21.75 in...
Articolo di analisi Nov 07

Investors Give Stratec SE (ETR:SBS) Shares A 35% Hiding

Stratec SE ( ETR:SBS ) shares have had a horrible month, losing 35% after a relatively good period beforehand. The drop...
Aggiornamento della narrazione Nov 03

SBS: Future Leadership Will Drive Healthcare Diagnostics Forward Amidst Margin Pressures

Analysts have revised their price target for Stratec downward from €36.58 to €33.30, citing expectations of slower revenue growth and a slight decrease in profit margins. What's in the News Tanja Bücherl will join STRATEC SE's Board of Management as Chief Financial Officer effective November 1, 2025.
Articolo di analisi Sep 23

Getting In Cheap On Stratec SE (ETR:SBS) Might Be Difficult

Stratec SE's ( ETR:SBS ) price-to-earnings (or "P/E") ratio of 25.3x might make it look like a sell right now compared...
Aggiornamento della narrazione Aug 23

Automation And Digitalization Will Transform Healthcare Diagnostics

Stratec’s consensus price target has been revised downward, primarily reflecting lowered forecasts for both revenue growth and net profit margin, resulting in a new fair value of €37.32. What's in the News Stratec increased its dividend to €0.60 per share for 2024 (previously €0.55), totaling €7.3 million to be distributed.
Articolo di analisi Jun 17

An Intrinsic Calculation For Stratec SE (ETR:SBS) Suggests It's 34% Undervalued

Key Insights Stratec's estimated fair value is €36.05 based on 2 Stage Free Cash Flow to Equity Stratec is estimated to...
Articolo di analisi Apr 25

Why We're Not Concerned About Stratec SE's (ETR:SBS) Share Price

With a price-to-earnings (or "P/E") ratio of 30.8x Stratec SE ( ETR:SBS ) may be sending very bearish signals at the...
User avatar
Nuova narrazione Feb 09

Efficiency Measures And Acquisitions Like Natech Will Boost Future Market Presence

Efficiency measures and cost discipline initiatives could enhance net margins as market conditions stabilize.
Articolo di analisi Jan 18

An Intrinsic Calculation For Stratec SE (ETR:SBS) Suggests It's 42% Undervalued

Key Insights Using the 2 Stage Free Cash Flow to Equity, Stratec fair value estimate is €55.10 Stratec's €32.10 share...
Articolo di analisi Nov 09

With A 25% Price Drop For Stratec SE (ETR:SBS) You'll Still Get What You Pay For

Stratec SE ( ETR:SBS ) shares have had a horrible month, losing 25% after a relatively good period beforehand. The drop...
Articolo di analisi Oct 26

Returns At Stratec (ETR:SBS) Appear To Be Weighed Down

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...
Articolo di analisi May 11

Here's Why It's Unlikely That Stratec SE's (ETR:SBS) CEO Will See A Pay Rise This Year

Key Insights Stratec to hold its Annual General Meeting on 17th of May Total pay for CEO Marcus Wolfinger includes...
Articolo di analisi Apr 11

Stratec's (ETR:SBS) Dividend Will Be Reduced To €0.55

Stratec SE's ( ETR:SBS ) dividend is being reduced from last year's payment covering the same period to €0.55 on the...
Articolo di analisi Apr 01

Stratec SE Just Missed EPS By 24%: Here's What Analysts Think Will Happen Next

Shareholders might have noticed that Stratec SE ( ETR:SBS ) filed its yearly result this time last week. The early...
Articolo di analisi Mar 28

Stratec (ETR:SBS) Has Announced That Its Dividend Will Be Reduced To €0.55

The board of Stratec SE ( ETR:SBS ) has announced it will be reducing its dividend by 43% from last year's payment of...
Articolo di analisi Dec 21

Is There An Opportunity With Stratec SE's (ETR:SBS) 36% Undervaluation?

Key Insights Stratec's estimated fair value is €67.40 based on 2 Stage Free Cash Flow to Equity Stratec's €43.00 share...
Articolo di analisi Nov 03

Slowing Rates Of Return At Stratec (ETR:SBS) Leave Little Room For Excitement

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Articolo di analisi Oct 19

We Think Stratec (ETR:SBS) Is Taking Some Risk With Its Debt

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Articolo di analisi Jul 12

Return Trends At Stratec (ETR:SBS) Aren't Appealing

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
Articolo di analisi Jun 27

Stratec SE (ETR:SBS) Shares Could Be 43% Below Their Intrinsic Value Estimate

Key Insights Stratec's estimated fair value is €110 based on 2 Stage Free Cash Flow to Equity Stratec is estimated to...
Articolo di analisi May 25

Is Stratec (ETR:SBS) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Previsioni di crescita degli utili e dei ricavi

XTRA:SBS - Stime future degli analisti e dati finanziari passati (EUR Millions )
DataRicaviUtiliFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/20282972016314
12/31/20272861818316
12/31/20262681424316
3/31/2026244-31024N/A
12/31/20252510-170N/A
9/30/202526015322N/A
6/30/202526415726N/A
3/31/2025266172543N/A
12/31/2024258163149N/A
9/30/2024256131834N/A
6/30/2024258171633N/A
3/31/202425212-116N/A
12/31/202327015219N/A
9/30/202325512-22-1N/A
6/30/202326219-31-11N/A
3/31/202326019-515N/A
12/31/202227529-910N/A
9/30/2022270281835N/A
6/30/2022269273755N/A
3/31/2022291403050N/A
12/31/2021287404363N/A
9/30/2021296464063N/A
6/30/2021286412953N/A
3/31/2021266352043N/A
12/31/202025028632N/A
9/30/202023524529N/A
6/30/202022521-420N/A
3/31/202022417-1215N/A
12/31/201921414N/A21N/A
9/30/201921214N/A8N/A
6/30/201920714N/A13N/A
3/31/201919511N/A9N/A
12/31/201818811N/A12N/A
9/30/201819316N/A20N/A
6/30/201819723N/A28N/A
3/31/201819824N/A28N/A
12/31/201720727N/A30N/A
9/30/201720828N/A30N/A
6/30/201720620N/A21N/A
3/31/201720319N/AN/AN/A
12/31/201618519N/A16N/A
9/30/201616614N/A17N/A
6/30/201615519N/A23N/A
3/31/201614421N/AN/AN/A
12/31/201514722N/A26N/A
9/30/201514722N/A35N/A
6/30/201514621N/A35N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Si prevede che SBS diventerà redditizio nei prossimi 3 anni, il che è considerato una crescita più rapida del tasso di risparmio ( 1.9% ).

Guadagni vs Mercato: Si prevede che SBS diventerà redditizia nei prossimi 3 anni, il che è considerato una crescita superiore alla media del mercato.

Guadagni ad alta crescita: Si prevede SBS diventerà redditizia nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di SBS ( 7.2% all'anno) crescerà più rapidamente del mercato German ( 6.8% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di SBS ( 7.2% all'anno) crescerà più lentamente di 20% all'anno.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di SBS sarà basso tra 3 anni ( 8.6 %).


Scoprire le aziende in crescita

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/05/21 14:12
Prezzo dell'azione a fine giornata2026/05/21 00:00
Utili2026/03/31
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Stratec SE è coperta da 11 analisti. 6 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Michael HeiderBerenberg
Jan KochDeutsche Bank
Jan KochDeutsche Bank